| Insulin-like Growth Factor-1 Receptor Inhibitor |
胰岛素样生长因子-1 受体拮抗剂 |
468740-43-4 |
| AFP464 |
AFP464 |
468719-52-0 |
| 5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
5-(3-苄氧基苯基)-7-[反式-3-[(吡咯烷-1-基)甲基]环丁基]-7H-吡咯并[2,3-D]嘧啶-4-胺 |
475488-23-4 |
| Alvespimycin |
阿螺旋霉素 |
467214-20-6 |
| Pazopanib |
帕唑帕尼 |
444731-52-6 |
| JAK INHIBITOR I |
2-(1,1-二甲基乙基)-9-氟-1,6-二氢-7H-苯并[H]咪唑并[4,5-F]异喹啉-7-酮 |
457081-03-7 |
| Vandetanib |
凡德他尼 |
443913-73-3 |
| Eribulin Mesylate |
甲磺酸艾日布林 |
441045-17-6 |
| MarizoMib |
马里佐米 |
437742-34-2 |
| macitentan |
马西替坦 |
441798-33-0 |
| VU 0357121 |
VU 0357121 |
433967-28-3 |
| Afatinib (BIBW 2992) |
阿法替尼 |
439081-18-2 |
| TAK-700 |
TAK-700 (ORTERONEL) |
426219-18-3 |
| 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione |
3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮 |
425637-18-9 |
| Lenvatinib |
乐伐替尼 |
417716-92-8 |
| Belinostat (PXD101) |
贝利司他(PXD101) |
414864-00-9 |
| Dovitinib |
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮 |
405169-16-6 |
| GW 3965 HYDROCHLORIDE |
2-[3-[3-[[2-氯-3-(三氟甲基)苄基](2,2-二苯基乙基)氨基]丙氧基]苯基]乙酸盐酸盐 |
405911-17-3 |
| 3-[3-[N-(2-CHLORO-3-TRIFLUOROMETHYLBENZYL)-(2,2-DIPHENYLETHYL)AMINO]PROPYLOXY]PHENYLACETIC ACID HYDROCHLORIDE |
3-[3-[[[2-氯-3-(三氟甲基)苯基]甲基](2,2-联苯基乙基)氨基]丙氧基]苯乙酸盐酸盐 |
405911-09-3 |
| Andarine |
SARM S4 |
401900-40-1 |
